Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Anti-proliferative composition

A technology for animals and uses, applied in the directions of drug combinations, active ingredients of hydrocarbon compounds, active ingredients of hydroxyl compounds, etc., can solve the problem of lack of ordinary technicians

Inactive Publication Date: 2012-06-27
NV NUTRICIA
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

These studies and others suggest that some plant components may act as active anti-proliferative agents, but teach the ordinary skilled person nothing about where to target the various components during the cycle of proliferating cells and which combinations may enhance the overall efficacy of the therapy

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0071] Compositions for treating prostate cancer

[0072] Mix the following ingredients:

[0073] Ingredient Amount per day (mg)

[0074] Soy Isoflavones 100.0

[0075] Lycopene 15.0

[0076] Silymarin 160.0

[0077] Antioxidants

[0078] Vitamin C 225.0

[0079] Vitamin E 75.0

[0080] Carotenoids 3.0

[0081] Flavonoids 19.0

[0082] Ubiquinol 4.0

[0083] Selenium 0.128

[0084] Zinc 18.0

[0085] Copper 2.7

[0086] Magnesium 5.0

[0087] Riboflavin 2.5

[0088] Vitamin B6 3.3

[0089] Vitamin B12 0.0033

[0090] Folic acid 0.4

[0091] N-acetyl-cysteine ​​500

Embodiment 2

[0093] Compositions for the treatment of colon cancer

[0094] Mix the following ingredients:

[0095] Ingredients Amount per day (mg)

[0096] Soy isoflavones 25.0

[0097] Lycopene 2.0

[0098] Silymarin 50.0

[0099] Fiber Mix 15000

[0100] Calcium 1500

[0101] Probiotics

[0102] Lactobacillus rhamnosus (Lb.rhamnosus) + Lactobacillus alcoholophilus (Lb.acidophilus)

[0103] 2-41010CFU

[0104] Antioxidants

[0105] Vitamin C 150.0

[0106] Vitamin E 37.5

[0107] Carotenoids 1.5

[0108] Flavonoids 10.0

[0109] Ubiquinol 2.0

[0110] Selenium 0.085

[0111] Zinc 9.0

[0112] Copper 1.4

[0113] Magnesium 2.5

[0114] Riboflavin 1.3

[0115] Vitamin B6 1.3

[0116] Vitamin B12 1.6

[0117] Folic acid 0.4

[0118] Green Tea Extract 300.0

[0119] Curcumin 60.0

Embodiment 3

[0121] 45g regular chocolate bar. The ingredients are: syrup, milk powder, chocolate pieces, cocoa butter, soybean lecithin and flavorings, wherein 1g of syrup is replaced by glycerin, and 1.5g of chocolate pieces are replaced by 50mg of milk thistle, 20mg of apigenin and 20mg of lycopene.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Non-estrogen-dependent hyperproliferation of cells in animals or humans can be prevented or treated by means of a pharmaceutical or nutritional composition containing a combination of at least three components from: a) two or more inhibitors of the G1 / S phase of the cell cycle; and b) two or more inhibitors of the G2 / M phase of the cell cycle; and c) two or more inhibitors of protein tyrosine kinase activity. Especially, component a) comprises two or more compounds selected from flavanolignans, carotenoids and isoflavone; component b) comprises two or more compounds selected from flavanolignans, hydroxylated stilbenes, isoflavones and apigenin; and component c) comprises two or more compounds selected from flavanolignans and isoflavones.

Description

field of invention [0001] The present invention relates to the use of a composition comprising a combination of inhibitors of different phases of the cell cycle and inhibitors of protein tyrosine kinases for the prevention and treatment of hyperproliferation of cells. Furthermore, the present invention also relates to compositions having these antiproliferative properties. Background of the invention [0002] In many cases, cellular hyperproliferation is an extremely undesirable process in humans and animals that leads to a variety of serious and sometimes fatal diseases. The most prominent of these diseases is cancer. Cancer accounts for a substantial portion of all human deaths in the world. For example, in the United States, 1.2 million new cases of invasive cancer are diagnosed each year, and approximately 500,000 people die from cancer each year. Cancer is the second leading cause of death and is expected to overtake heart disease in the early 21st century to rank fi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K45/06A61P35/00A61P17/06A61K45/00A23L23/00A23L33/105A23L33/135A23L33/15A23L33/16A23L33/21A61K31/07A61K31/366A61K36/48A61P13/08
CPCA61K31/353A23L1/308A23L1/302A23L1/304A61K31/352A61K31/375A23L1/39A23L1/3002A61K45/06A61K36/736A61K31/01A23L1/3014A61K36/28A61K36/889A23L23/00A23L33/105A23L33/135A23L33/15A23L33/16A23L33/21A61P13/08A61P17/06A61P35/00
Inventor 阿德里亚努斯·兰伯特斯·贝特霍尔德斯·范海尔沃尔特克拉斯克·范诺伦罗伯特·约翰·约瑟夫·哈格曼温迪·安托瓦妮特·维尔维利根米瑞恩·兰辛克
Owner NV NUTRICIA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com